Exploring the Mechanisms of Action of the Novel Microtubule Inhibitor Vinflunine

Seminars in Oncology

Volumn 35, Issue SUPPL 3, 2008, Pages

  Jordan, Mary Ann ^a   Horwitz, Susan Band ^b   Lobert, Sharon ^c   Correia, John J ^c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^c UNIVERSITY OF MISSISSIPPI MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA TUBULIN; DOCETAXEL; NAVELBINE; PACLITAXEL; TAXANE DERIVATIVE; VINBLASTINE; VINCA ALKALOID; VINCRISTINE; VINFLUNINE;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; BINDING AFFINITY; BREAST CANCER; CANCER CELL; CANCER RESISTANCE; CANCER SURVIVAL; CELL CYCLE ARREST; CELL CYCLE PROGRESSION; CELL MIGRATION; CELL PROLIFERATION; DRUG BINDING; DRUG EFFECT; DRUG EFFICACY; DRUG MECHANISM; DRUG PROTEIN BINDING; DRUG RESEARCH; HEMATOLOGIC MALIGNANCY; HUMAN; LUNG NON SMALL CELL CANCER; MICROTUBULE; MITOSIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; TREATMENT RESPONSE;

ANTINEOPLASTIC AGENTS, PHYTOGENIC; CELL CYCLE; CELL DEATH; DRUG DELIVERY SYSTEMS; HUMANS; MICROTUBULES; MITOSIS; TUBULIN MODULATORS; VINBLASTINE;

EID: 44449128533     PISSN: 00937754     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.seminoncol.2008.01.009     Document Type: Article

References (65)

1. Alberts B., Johnson A., Lewis J., Raff M., Roberts K., Walter P., et al. Macromolecules: Structure, Shape, and Information. Molecular biology of the cell. 4th ed. (2002), Garland Publishing, Oxford, UK 89-138
2. Jordan M.A., and Wilson L. Microtubules as a target for anticancer drugs. Nat Rev Cancer 4 (2004) 253-265
3. Verdier-Pinard P., Wang F., Burd B., Angeletti R.H., Horwitz S.B., and Orr G.A. Direct analysis of tubulin expression in cancer cell lines by electrospray ionization mass spectrometry. Biochemistry 42 (2003) 12019-12027
4. Cassimeris L. The oncoprotein 18/stathmin family of microtubule destabilizers. Curr Opin Cell Biol 14 (2002) 18-24
5. Giodini A., Kallio M.J., Wall N.R., Gorbsky G.J., Toqnin S., Marchisio P.C., et al. Regulation of microtubule stability and mitotic progression by survivin. Cancer Res 62 (2002) 2462-2467
6. Maney T., Wagenbach M., and Wordeman L. Molecular dissection of the microtubule depolymerizing activity of mitotic centromere-associated kinesin. J Biol Chem 276 (2001) 34753-34758
7. Spittle C., Charrasse S., Larroque C., and Cassimeris L. The interaction of TOGp with microtubules and tubulin. J Biol Chem 275 (2000) 20748-20753
8. Desai A., and Mitchison T.J. Microtubule polymerization dynamics. Annu Rev Cell Dev Biol 13 (1997) 83-117
9. McNally F.J. Modulation of microtubule dynamics during the cell cycle. Curr Opin Cell Biol 8 (1996) 23-29
10. Nogales E. Structural insight into microtubule function. Annu Rev Biophys Biomol Struct 30 (2001) 397-420
11. Chen W., and Zhang D. Kinetochore fibre dynamics outside the context of the spindle during anaphase. Nat Cell Biol 6 (2004) 227-231
12. Mitchison T.J. Polewards microtubule flux in the mitotic spindle: Evidence from photoactivation of fluorescence. J Cell Biol 109 (1989) 637-652
13. Wilson P.J., and Forer A. Effects of nanomolar taxol on crane-fly spermatocyte spindles indicate that acetylation of kinetochore microtubules can be used as a marker of poleward tubulin flux. Cell Motil Cytoskeleton 37 (1997) 20-32
14. Hayden J.H., Bowser S.S., and Rieder C.L. Kinetochores capture astral microtubules during chromosome attachment to the mitotic spindle: direct visualization in live newt lung cells. J Cell Biol 111 (1990) 1039-1045
15. Li X., and Nicklas R.B. Mitotic forces control a cell-cycle checkpoint. Nature 373 (1995) 630-632
16. Mitchison T., and Kirschner M. Dynamic instability of microtubule growth. Nature 312 (1984) 237-242
17. Margolis R.L., and Wilson L. Microtubule treadmilling: What goes around comes around. Bioessays 20 (1998) 830-836
18. Walker R.A., O'Brien E.T., Pryer N.K., et al. Dynamic instability of individual microtubules analyzed by video light microscopy: rate constants and transition frequencies. J Cell Biol 107 (1988) 1437-1448
19. Rodionov V.I., and Borisy G.G. Microtubule treadmilling in vivo. Science 275 (1997) 215-218
20. Waters J.C., Mitchison T.J., Rieder C.L., and Salmon E.D. The kinetochore microtubule minus-end disassembly associated with poleward flux produces a force that can do work. Mol Biol Cell 7 (1996) 1547-1558
21. Waterman-Storer C.M., and Salmon E.D. Microtubule dynamics: Treadmilling comes around again. Curr Biol 7 (1997) R369-R372
22. Jordan M.A. Mechanism of action of antitumor drugs that interact with microtubules and tubulin. Curr Med Chem Anticancer Agents 2 (2002) 1-17
23. Correia J.J., and Lobert S. Physiochemical aspects of tubulin-interacting antimitotic drugs. Curr Pharm Des 7 (2001) 1213-1228
24. Compton D.A. Spindle assembly in animal cells. Annu Rev Biochem 69 (2000) 95-114
25. Gardner R.D., and Burke D.J. The spindle checkpoint: Two transitions, two pathways. Trends Cell Biol 10 (2000) 154-158
26. Jordan M.A., Toso R.J., Thrower D., and Wilson L. Mechanism of mitotic block and inhibition of cell proliferation by taxol at low concentrations. Proc Natl Acad Sci U S A 90 (1993) 9552-9556
27. Jordan M.A., Wendell K., Gardiner S., Derry W.B., Copp H., and Wilson L. Mitotic block induced in HeLa cells by low concentrations of paclitaxel (Taxol) results in abnormal mitotic exit and apoptotic cell death. Cancer Res 56 (1996) 816-825
28. Johnson I.S., Armstrong J.G., Gorman M., and Burnett Jr. J.P. The vinca alkaloids: A new class of oncolytic agents. Cancer Res 23 (1963) 1390-1427
29. Na G.C., and Timasheff S.N. Thermodynamic linkage between tubulin self-association and the binding of vinblastine. Biochemistry 19 (1980) 1355-1365
30. Lobert S., and Correia J.J. Energetics of vinca alkaloid interactions with tubulin. Methods Enzymol 323 (2000) 77-103
31. Wani M.C., Taylor H.L., Wall M.E., Coggon P., and McPhail A.T. Plant antitumor agents. VI. The isolation and structure of taxol, a novel antileukemic and antitumor agent from Taxus brevifolia. J Am Chem Soc 93 (1971) 2325-2327
32. Nogales E., Wolf S.G., Khan I.A., Luduena R.F., and Downing K.H. Structure of tubulin at 6.5 A and location of the taxol-binding site. Nature 375 (1995) 424-427
33. Horwitz S.B. Taxol (paclitaxel): Mechanisms of action. Ann Oncol 5 Suppl 6 (1994) S3-S6
34. Derry W.B., Wilson L., and Jordan M.A. Substoichiometric binding of taxol suppresses microtubule dynamics. Biochemistry 34 (1995) 2203-2211
35. Yvon A.M., Wadsworth P., and Jordan M.A. Taxol suppresses dynamics of individual microtubules in living human tumor cells. Mol Biol Cell 10 (1999) 947-959
36. Fahy J., Duflos A., Ribet J.P., et al. Vinca alkaloids in superacidic media: A method for creating a new family of antitumor derivatives. J Am Chem Soc 119 (1997) 8576-8577
37. Jacquesy J.C., and Fahy J. Cancer: superacid generation of new antitumor agents. In: Torrence P.F. (Ed). Biomedical chemistry; applying chemical principles to the understanding and treatment of disease (2000), Wiley-Interscience, New York, NY 227-246
38. Kruczynski A., Colpaert F., Tarayre J.P., Mouillard P., Fahy J., and Hill B.T. Preclinical in vivo antitumor activity of vinflunine, a novel fluorinated Vinca alkaloid. Cancer Chemother Pharmacol 41 (1998) 437-447
39. Hill B.T., Fiebig H.H., Waud W.R., Poupon M.F., Colpaert F., and Kruczynski A. Superior in vivo experimental antitumour activity of vinflunine, relative to vinorelbine, in a panel of human tumour xenografts. Eur J Cancer 35 (1999) 512-520
40. Kruczynski A., Barret J.M., Etiévant C., Colpaert F., Fahy J., and Hill B.T. Antimitotic and tubulin-interacting properties of vinflunine, a novel fluorinated Vinca alkaloid. Biochem Pharmacol 55 (1998) 635-648
41. Jean-Decoster C., Brichese L., Barret J.M., Tollon Y., Kruczynski A., and Hill B.T. Vinflunine, a new vinca alkaloid: cytotoxicity, cellular accumulation and action on the interphasic and mitotic microtubule cytoskeleton of PtK2 cells. Anticancer Drugs 10 (1999) 537-543
42. Kruczynski A., and Hill B.T. Vinflunine, the latest Vinca alkaloid in clinical development. A review of its preclinical anticancer properties. Crit Rev Oncol Hematol 40 (2001) 159-173
43. Okouneva T., Hill B.T., Wilson L., and Jordan M.A. The effects of vinflunine, vinorelbine, and vinblastine on centromere dynamics. Mol Cancer Ther 2 (2003) 427-436
44. Ngan V.K., Bellman K., Panda D., Hill B.T., Jordan M.A., and Wilson L. Novel actions of the antitumor drugs vinflunine and vinorelbine on microtubules. Cancer Res 60 (2000) 5045-5051
45. Lobert S., Fahy J., Hill B.T., Duflos A., Etievant C., and Correia J.J. Vinca alkaloid-induced tubulin spiral formation correlates with cytotoxicity in the leukemic L1210 cell line. Biochemistry 39 (2000) 12053-12062
46. Lobert S., Ingram J.W., Hill B.T., and Correia J.J. A comparison of thermodynamic parameters for vinorelbine- and vinflunine-induced tubulin self-association by sedimentation velocity. Mol Pharmacol 53 (1998) 908-915
47. Ngan V.K., Bellman K., Hill B.T., Wilson L., and Jordan M.A. Mechanism of mitotic block and inhibition of cell proliferation by the semisynthetic Vinca alkaloids vinorelbine and its newer derivative vinflunine. Mol Pharmacol 60 (2001) 225-232
48. Gidding C.E., Kellie S.J., Kamps W.A., and de Graaf S.S. Vincristine revisited. Crit Rev Oncol Hematol 29 (1999) 267-287
49. Sahenk Z., Barohn R., New P., and Mendell J.R. Taxol neuropathy. Electrodiagnostic and sural nerve biopsy findings. Arch Neurol 51 (1994) 726-729
50. Etiévant C., Barret J.M., Kruczynski A., Perrin D., and Hill B.T. Vinflunine (20′,20′-difluoro-3′,4′-dihydrovinorelbine), a novel Vinca alkaloid, which participates in P-glycoprotein (Pgp)-mediated multidrug resistance in vivo and in vitro. Invest New Drugs 16 (1998) 3-17
51. Etiévant C., Kruczynski A., Barret J.M., Tait A.S., Kavallaris M., and Hill B.T. Markedly diminished drug resistance-inducing properties of vinflunine (20′,20′-difluoro-3′,4′-dihydrovinorelbine) relative to vinorelbine, identified in murine and human tumour cells in vivo and in vitro. Cancer Chemother Pharmacol 48 (2001) 62-70
52. Aggarwal A, Kruczynski A, Frankfurter A, Correia JJ, Lobert S. Murine leukemia cell lines are sensitive to vinflunine. Invest New Drugs. 2007 (in press).
53. Oakley B.R. An abundance of tubulins. Trends Cell Biol 10 (2000) 537-542
54. Sharp D.J., Rogers G.C., and Scholey J.M. Microtubule motors in mitosis. Nature 407 (2000) 41-47
55. Luduena R.F. Multiple forms of tubulin: different gene products and covalent modifications. Int Rev Cytol 178 (1998) 207-275
56. Verdier-Pinard P., Shahabi S., Wang F., Burd B., Xiao H., Goldberg G.L., et al. Detection of human βV-tubulin expression in epithelial cancer cell lines by tubulin proteomics. Biochemistry 44 (2005) 15858-15870
57. Bhattacharya R., and Cabral F. A ubiquitous b-tubulin disrupts microtubule assembly and inhibits cell proliferation. Mol Biol Cell 15 (2004) 3123-3131
58. Panda D., Miller H.P., Banerjee A., Luduena R.F., and Wilson L. Microtubule dynamics in vitro are regulated by the tubulin isotype composition. Proc Natl Acad Sci U S A 91 (1994) 11358-11362
59. Derry W.B., Wilson L., Khan I.A., Luduena R.F., and Jordan M.A. Taxol differentially modulates the dynamics of microtubules assembled from unfractionated and purified beta-tubulin isotypes. Biochemistry 36 (1997) 3554-3562
60. Kamath K., Wilson L., Cabral F., and Jordan M.A. βIII-tubulin induces paclitaxel resistance in association with reduced effects on microtubule dynamic instability. J Biol Chem 280 (2005) 12902-12907
61. Burkhart C.A., Kavallaris M., and Horwitz S.B. The role of beta-tubulin isotypes in resistance to antimitotic drugs. Biochim Biophys Acta 1471 (2001) O1-O9
62. Banerjee A. Increased levels of tyrosinated alpha-, beta(III)-, and beta(IV)-tubulin isotypes in paclitaxel-resistant MCF-7 breast cancer cells. Biochem Biophys Res Commun 293 (2002) 598-601
63. Sève P., Mackey J., Isaac S., Trédan O., Souquet P.-J., and Pérol M. Class III β-tubulin expression in tumor cells predicts response and outcome in patients with non-small cell lung cancer receiving paclitaxel. Mol Cancer Ther 4 (2005) 2001-2007
64. Sève P., Isaac S., Trédan O., Souquet P.-J., Pachéco Y., and Pérol M. Expression of class III β-tubulin is predictive of patient outcome in patients with non-small cell lung cancer receiving vinorelbine-based chemotherapy. Clin Cancer Res 11 (2005) 5481-5486
65. Bernard-Marty C., Treilleux I., Dumontet C., Cardoso F., Fellows A., and Gancberg D. Microtubule-associated parameters as predictive markers of docetaxel activity in advanced breast cancer patients: results of a pilot study. Clin Breast Cancer 3 (2002) 341-345